Korify Capital
Venture capitalSeries A–Late Stage · 3 people tracked
Investment thesis
Korify Capital invests in companies advancing longevity and mental health, aiming to help people live long, healthy, and fulfilled lives. The firm backs unique, pioneering approaches led by strong teams that are redefining their sectors. Its investment focus is on Series A through Series C rounds in companies that have demonstrated strong traction, achieved proof of concept, and are positioned to become future leaders in their fields.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website
Serial angel investor and entrepreneur who founded the family office Infinitas Capital and has over 10 years of experience in VC, real estate, and building ventures. He holds a BSc in Business Administration from Basel University and an MSc in Entrepreneurship from Cass Business School.
Co-founder of Korify Capital who previously worked as a consultant to big pharma at EY. He holds a BA in Business and Economics from the University of Basel.
What they invest in
from 3 of 20 portfolio companiesBiotech ×3Medical Devices ×2FemTech ×1Healthtech ×1Longevity ×1
HQs:United States×2
Investments · 20 tracked
founders shown can be your intro pathAI-powered platform enhancing patient-centered care with personalized health plans and provider insights.
BiotechMountain View, US
Adam Savitz(Executive Officer)Amit Etkin(Executive Officer, Director)Nicholas C. Smith(Executive Officer)Gwill C. York(Director)Husseini Nixon Manji(Director)Christopher Nixon Cox(Director)
AI-enabled biomarker platform for developing personalized and effective medicines, based on Stanford research.
Biotech company developing small molecule therapeutics to activate cellular quality control machinery for treating neurodegenerative diseases.
Distributed development company building a pipeline of therapies to prevent age-related illness and extend healthspan.
Cambrian Bio is a clinical-stage biopharmaceutical company developing precision therapeutics targeting metabolic pathways associated with aging, including AMPK and mTOR.
BiotechLongevityMedical Devices
Integrated biotech company investing in and supporting innovators in aging to transform scientific discoveries into medicines for age-related disorders.
Biopharmaceutical company developing therapies against cancer and chronic diseases through selective elimination of cellular senescence.
Biotechnology company applying cellular reprogramming to improve fertility and address age-related reproductive health through ovarian cell innovation.
Biotech company developing small-molecule therapies targeting the nuclear envelope to treat age-related diseases.
Company developing therapeutic medicines targeting FOXO proteins to treat age-related diseases and improve healthy longevity.
Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
US-based toy company specializing in screenless audio platforms for children focused on stage-based learning and emotional development.
Frequently asked questions
- What stage does Korify Capital invest at?
- Korify Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Korify Capital focus on?
- Korify Capital focuses on AI & Machine Learning, Biotech, Healthtech, Longevity, Mental Health.
Images
Similar investors
GV (formerly Google Ventures) is a venture capital firm backing companies across AI applications, healthcare, developer tools and security, and infrastructure.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
MPM BioImpact is a life sciences investment firm that creates, builds, and invests in biotechnology and healthcare companies developing transformative medicines, spanning both private company creation and public market investing.
Kinnevik is a leading growth investor, active owner, and operational partner providing patient capital to technology-enabled challenger businesses in Europe and the US.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.